Context Therapeutics (CNTX) Return on Assets (2021 - 2026)

Context Therapeutics has disclosed Return on Assets across 6 years of filings, most recently posting 0.01% for Q1 2026.

• Return on Assets for Q1 2026 came in at 0.01%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.01% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Assets came in at 0.01% for Q1 2026 at Context Therapeutics, down from 0.0% in the prior quarter.
• In the past five years, Return on Assets ranged from a high of 0.0% in Q2 2022 to a low of 0.02% in Q1 2024.
• The 5-year median for Return on Assets is 0.0% (2025), against an average of 0.01%.
• Across the five-year window, Return on Assets fell 1 bps in 2023 and grew 1 bps in 2024, its largest moves.
• Context Therapeutics' Return on Assets stood at 0.0% in 2022, then sank by 234 bps to 0.01% in 2023, then jumped by 77 bps to 0.0% in 2024, then tumbled by 70 bps to 0.0% in 2025, then decreased by 30 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.